Matt Eisgrau, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 629 Partridge Cir Unit B, Golden, CO 80403 Phone: 303-877-4540 |
Cheryl Botsford, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1899 Denver West Dr Apt 1423, Golden, CO 80401 Phone: 262-573-1920 |
Barbara Buckmaster, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1819 Denver West Dr, 26-200, Golden, CO 80401 Phone: 303-422-9438 Fax: 303-422-9474 |
Amanda L Selby, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1819 Denver West Dr, 200, Golden, CO 80401 Phone: 303-422-9438 Fax: 303-422-9474 |
News Archive
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has granted PROCAPS S.A. exclusive rights to market and sell DAVANATĀ® to treat cancer in Colombia, South America. Phase ll clinical trial results for late-stage colorectal cancer patients demonstrate that when DAVANATĀ® is co-administered with the chemotherapy drug 5-FU, survival increased by 46% over the best standard of care and reduced serious adverse events associated with chemotherapy.
Lung cancer is one of the most common primary cancers that cause leptomeningeal carcinomatosis (LMC), when cancer spreads to the membranes surrounding the spinal cord and brain. Cases of LMC have increased because of the improved survival of lung cancer patients with the help of new advances in treatment.
St. Luke's University Health Network is pleased to announce Richard Baker III, MD, has returned to St. Luke's University Health Network as the head of St. Luke's OB/GYN at Eaton Pointe. Angela MacMillan, CRNP, also joins the practice at 800 Eaton Ave., Suite 202, Bethlehem. The two have been in practice together for eight years.
Fewer than half of American adults get vaccinated despite strong recommendations from the Centers for Disease Control and Prevention and widespread availability of free and low-cost vaccines.
Guardant Health today announced that five abstracts submitted by the University of California, San Francisco; University of California, San Diego; and MD Anderson highlighting the performance and clinical utility of Guardant360 have been accepted for oral and poster presentations at the 2015 American Society of Clinical Oncology Annual Meeting in Chicago, May 29-June 2.
› Verified 7 days ago